Literature DB >> 20093753

Nanovaccines: recent developments in vaccination.

Tarala D Nandedkar1.   

Abstract

In the past 100 years, vaccination has contributed immensely to public health by preventing a number of infectious diseases. Attenuated, killed or part of the microorganism is employed to stimulate the immune system against it. Progress in biotechnology has provided protective immunity through DNA vaccines. In recent years, nanovaccine is a novel approach to the methodology of vaccination. Nanomaterials are delivered in the form of microspheres, nanobeads or micro-nanoprojections. Painless, effective and safe needle-free routes such as the intranasal or the oral route, or patches of microprojections to the skin are some of the approaches which are in the experimental stage at present but may have a great future ahead in nanovaccination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20093753     DOI: 10.1007/s12038-009-0114-3

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   2.795


  34 in total

1.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

2.  Systemic immune responses in sheep, induced by a novel nano-bead adjuvant.

Authors:  Jean-Pierre Y Scheerlinck; Simone Gloster; Anita Gamvrellis; Patricia L Mottram; Magdalena Plebanski
Journal:  Vaccine       Date:  2005-09-19       Impact factor: 3.641

Review 3.  Toxic potential of materials at the nanolevel.

Authors:  Andre Nel; Tian Xia; Lutz Mädler; Ning Li
Journal:  Science       Date:  2006-02-03       Impact factor: 47.728

Review 4.  Application of nanotechnology in biomedicine.

Authors:  Rajshri M Navalakhe; Tarala D Nandedkar
Journal:  Indian J Exp Biol       Date:  2007-02       Impact factor: 0.818

Review 5.  Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.

Authors:  Sameer Sharma; T K S Mukkur; Heather A E Benson; Yan Chen
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

6.  Nanotechnology. Can high-speed tests sort out which nanomaterials are safe?

Authors:  Robert F Service
Journal:  Science       Date:  2008-08-22       Impact factor: 47.728

7.  Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.

Authors:  Xiao-Wen He; Fang Wang; Lei Jiang; Jun Li; Shan-Kui Liu; Zhen-Yu Xiao; Xiao-Qin Jin; Ya-Nan Zhang; Ying He; Kai Li; Ying-Jun Guo; Shu-Han Sun
Journal:  J Gen Virol       Date:  2005-03       Impact factor: 3.891

Review 8.  Nature and duration of protective immunity to bluetongue virus infection.

Authors:  P Roy
Journal:  Dev Biol (Basel)       Date:  2003

Review 9.  New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles.

Authors:  P Roy; G Sutton
Journal:  Arch Virol Suppl       Date:  1998

Review 10.  Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.

Authors: 
Journal:  Drugs R D       Date:  2003
View more
  10 in total

1.  Effects of antigen-expressing immunostimulatory liposomes on chemotaxis and maturation of dendritic cells in vitro and in human skin explants.

Authors:  Anastasia Lanzi; Cynthia M Fehres; Tanja D de Gruijl; Yvette van Kooyk; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2013-09-26       Impact factor: 4.200

Review 2.  Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.

Authors:  Azam Bolhassani; Shabnam Javanzad; Tayebeh Saleh; Mehrdad Hashemi; Mohammad Reza Aghasadeghi; Seyed Mehdi Sadat
Journal:  Hum Vaccin Immunother       Date:  2013-10-15       Impact factor: 3.452

3.  Novel antigen delivery technologies: a review.

Authors:  Deepika Jain; Vikas Jain; Ranjit Singh
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

Review 4.  Potential applications and human biosafety of nanomaterials used in nanomedicine.

Authors:  Hong Su; Yafei Wang; Yuanliang Gu; Linda Bowman; Jinshun Zhao; Min Ding
Journal:  J Appl Toxicol       Date:  2017-06-06       Impact factor: 3.446

5.  Recombinant PBP2a/autolysin conjugate as PLGA-based nanovaccine induced humoral responses with opsonophagocytosis activity, and protection versus methicillin-resistant Staphylococcus aureus infection.

Authors:  Setareh Haghighat; Seyed Davar Siadat; Abbas Akhavan Sepahi; Mehdi Mahdavi
Journal:  Iran J Basic Med Sci       Date:  2022-04       Impact factor: 2.532

Review 6.  COVID-19 vaccines and nanomedicine.

Authors:  Robert S Shapiro
Journal:  Int J Dermatol       Date:  2021-06-05       Impact factor: 3.204

Review 7.  An ecological and conservation perspective on advances in the applied virology of zoonoses.

Authors:  Kurt J Vandegrift; Nina Wale; Jonathan H Epstein
Journal:  Viruses       Date:  2011-04-15       Impact factor: 5.818

8.  Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal model.

Authors:  Linda Petrone; Maria G Ammendolia; Armando Cesolini; Stefano Caimi; Fabiana Superti; Colomba Giorgi; Paola Di Bonito
Journal:  J Transl Med       Date:  2011-05-18       Impact factor: 5.531

Review 9.  Future perspectives on swine viral vaccines: where are we headed?

Authors:  Tanja Opriessnig; Ashley A Mattei; Anbu K Karuppannan; Patrick G Halbur
Journal:  Porcine Health Manag       Date:  2021-01-04

Review 10.  Modulation of antigen-specific T-cells as immune therapy for chronic infectious diseases and cancer.

Authors:  Suling Li; Alistair L J Symonds; Tizong Miao; Ian Sanderson; Ping Wang
Journal:  Front Immunol       Date:  2014-06-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.